C07K 14/025
Papovaviridae
Official title: Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
C07K14/025 (Papovaviridae) appears on 49 US grants and 102 published applications in this corpus.
Search patents in C07K- Granted patents
- 49
- Published applications
- 102
- Assignees
- 59
- Inventors
- 209
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 4 |
| 2017 | 3 | 6 |
| 2018 | 5 | 11 |
| 2019 | 5 | 10 |
| 2020 | 5 | 5 |
| 2021 | 6 | 9 |
| 2022 | 6 | 7 |
| 2023 | 4 | 13 |
| 2024 | 4 | 8 |
| 2025 | 5 | 16 |
| 2026 | 4 | 8 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Cell capable of activating immune system, and pharmaceutical composition containing said cell11 Aug 2026US 12,703,867 B2Riken
- Compositions comprising annexin V and HPV tumor antigen fusion polypeptides and methods for making and use9 Jun 2026US 12,649,767 B2The Johns Hopkins University
- Methods for treating HPV-associated diseases14 Apr 2026US 12,599,656 B2
- Vaccines for recurrent respiratory papillomatosis and methods of using the same25 Nov 2025US 12,478,667 B2Inovio Pharmaceuticals, Inc.
- Cpg amphiphiles and uses thereof3 Sep 2026US 2026/0258090 A1Elicio Therapeutics, Inc.
- Method for production of virus-like particles for gene delivery27 Aug 2026US 2026/0250644 A1Carnegie Mellon University
- Modified long peptides suitable for use in immunisation16 Jul 2026US 2026/0200990 A1Isabella Pharma B.V.
- Methods for treating hpv-associated diseases2 Jul 2026US 2026/0183378 A1Stemcell Technologies Canada Inc.
- Pepmixes to generate multiviral ctls with broad specificity2 Apr 2026US 2026/0092256 A1Baylor College of Medicine
Most cited
By later US patents
- Virus-like particle conjugates for diagnosis and treatment of tumors14US 10,117,947 B2Aura Biosciences, Inc. · 2018
- Therapeutic HPV18 vaccines9US 9,790,256 B2Janssen Vaccines & Prevention B. V. · 2017
- HPV vaccines6US 10,669,315 B2Hookipa Biotech GmbH · 2020
- Pepmixes to generate multiviral CTLs with broad specificity5US 11,118,164 B2Baylor College of Medicine · 2021
- Therapeutic HPV16 vaccines4US 10,071,151 B2Janssen Vaccines & Prevention B. V. · 2018